相关实验视频
Updated: Jul 3, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
415
E2F1和E2F2单核酸多形态与喉状细胞癌的关联具有病态特征
Tomas Jakstas1, Agne Bartnykaite2, Evaldas Padervinskis3
1Department of Otorhinolaryngology, Lithuanian University of Health Sciences, Kaunas, Lithuania. tomas.jakstas@lsmu.lt.
BMC cancer
|February 15, 2024
概括
E2F2和E2F1中的特定基因变异会影响喉状细胞癌 (LSCC) 的攻击性,影响瘤分化和淋巴结参与,但不会影响整体存活率.
科学领域:
- 遗传学 遗传学 是一个
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 喉平细胞癌 (LSCC) 呈现出高死亡率和晚期的预后不佳.
- 确定LSCC的特定预后血液基标记物对于改善患者的治疗结果至关重要.
- 本研究研究了单核酸多态 (SNP) 在LSCC发育和进展中的作用.
研究的目的:
- 评估E2F1和E2F2基因中的四个SNP对LSCC发育的影响.
- 评估这些SNP与LSCC形态特征之间的关联.
- 确定这些SNP与患者5年生存率的相关性.
主要方法:
- 使用RT-PCR对200名LSCC患者和200名对照患者的基因定型.
- 分析了四个SNP:E2F1 (rs3213183,rs3213180) 和E2F2 (rs2075993,rs3820028). 这两种SNP的分析结果是:
- 评估与LSCC风险,临床表现和5年生存率的关联.
主要成果:
- 分析的SNP与LSCC发展之间没有发现直接关联.
- E2F2 rs2075993 G等位基因和rs3820028 A等位基因携带者表现出差分化LSCC的风险明显更高.
- E2F1 rs3213180 GC异构菌对淋巴结参与的风险增加.
结论:
- E2F2基因变体rs2075993和rs3820028与LSCC分化有关.
- E2F1基因变体rs3213180与LSCC中的淋巴结参与有关.
- 研究的SNP与LSCC患者的5年生存率之间没有明显的关联.
相关概念视频
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K

